These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 19435406)

  • 21. Nanoparticle transport across the blood brain barrier.
    Grabrucker AM; Ruozi B; Belletti D; Pederzoli F; Forni F; Vandelli MA; Tosi G
    Tissue Barriers; 2016; 4(1):e1153568. PubMed ID: 27141426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nanodelivery systems for overcoming limited transportation of therapeutic molecules through the blood-brain barrier.
    Kim KT; Lee HS; Lee JJ; Park EK; Lee BS; Lee JY; Bae JS
    Future Med Chem; 2018 Nov; 10(22):2659-2674. PubMed ID: 30499740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier.
    Sharma G; Sharma AR; Lee SS; Bhattacharya M; Nam JS; Chakraborty C
    Int J Pharm; 2019 Mar; 559():360-372. PubMed ID: 30721725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transport of drugs across the blood-brain barrier by nanoparticles.
    Wohlfart S; Gelperina S; Kreuter J
    J Control Release; 2012 Jul; 161(2):264-73. PubMed ID: 21872624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blood-brain barrier transport of drugs for the treatment of brain diseases.
    Gabathuler R
    CNS Neurol Disord Drug Targets; 2009 Jun; 8(3):195-204. PubMed ID: 19601817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PLGA nanoparticles prepared by nano-emulsion templating using low-energy methods as efficient nanocarriers for drug delivery across the blood-brain barrier.
    Fornaguera C; Dols-Perez A; Calderó G; García-Celma MJ; Camarasa J; Solans C
    J Control Release; 2015 Aug; 211():134-43. PubMed ID: 26057857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting receptor-ligand chemistry for drug delivery across blood-brain barrier in brain diseases.
    Anthony DP; Hegde M; Shetty SS; Rafic T; Mutalik S; Rao BSS
    Life Sci; 2021 Jun; 274():119326. PubMed ID: 33711385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Central nervous system delivery of molecules across the blood-brain barrier.
    Gosselet F; Loiola RA; Roig A; Rosell A; Culot M
    Neurochem Int; 2021 Mar; 144():104952. PubMed ID: 33400964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases.
    Gabathuler R
    Neurobiol Dis; 2010 Jan; 37(1):48-57. PubMed ID: 19664710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel drug-delivery approaches to the blood-brain barrier.
    Wang X; Yu X; Vaughan W; Liu M; Guan Y
    Neurosci Bull; 2015 Apr; 31(2):257-64. PubMed ID: 25595370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the RBE4 cell line to explore carrier-mediated drug delivery to the CNS via the L-system amino acid transporter at the blood-brain barrier.
    Reichel A; Abbott NJ; Begley DJ
    J Drug Target; 2002 Jun; 10(4):277-83. PubMed ID: 12164376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current Strategies for Brain Drug Delivery.
    Dong X
    Theranostics; 2018; 8(6):1481-1493. PubMed ID: 29556336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New systems for delivery of drugs to the brain in neurological disease.
    Cornford EM; Cornford ME
    Lancet Neurol; 2002 Sep; 1(5):306-15. PubMed ID: 12849428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nano carriers for drug transport across the blood-brain barrier.
    Li X; Tsibouklis J; Weng T; Zhang B; Yin G; Feng G; Cui Y; Savina IN; Mikhalovska LI; Sandeman SR; Howel CA; Mikhalovsky SV
    J Drug Target; 2017 Jan; 25(1):17-28. PubMed ID: 27126681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanotechnology approaches to crossing the blood-brain barrier and drug delivery to the CNS.
    Silva GA
    BMC Neurosci; 2008 Dec; 9 Suppl 3(Suppl 3):S4. PubMed ID: 19091001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surfactants, not size or zeta-potential influence blood-brain barrier passage of polymeric nanoparticles.
    Voigt N; Henrich-Noack P; Kockentiedt S; Hintz W; Tomas J; Sabel BA
    Eur J Pharm Biopharm; 2014 May; 87(1):19-29. PubMed ID: 24607790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emerging Technologies for Delivery of Biotherapeutics and Gene Therapy Across the Blood-Brain Barrier.
    Stanimirovic DB; Sandhu JK; Costain WJ
    BioDrugs; 2018 Dec; 32(6):547-559. PubMed ID: 30306341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Upconversion Nanoparticle-Based Strategy for Crossing the Blood-Brain Barrier to Treat the Central Nervous System Disease.
    Fu L; Chung R; Shi B
    Methods Mol Biol; 2019; 2054():263-282. PubMed ID: 31482461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Active Targeting Towards and Inside the Brain based on Nanoparticles: A Review.
    Rabiei M; Kashanian S; Samavati SS; Jamasb S; McInnes SJP
    Curr Pharm Biotechnol; 2020; 21(5):374-383. PubMed ID: 31793421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The blood-brain barrier: clinical implications for drug delivery to the brain.
    De Boer AG; Breimer DD
    J R Coll Physicians Lond; 1994; 28(6):502-6. PubMed ID: 7884704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.